Current Ratio of Y-mAbs Therapeutics, Inc. from 30 Jun 2019 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Y-mAbs Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Current Ratio for the quarter ending 30 Jun 2025 was 418%, a 6.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2025 418% -30% -6.6% 30 Jun 2025
Q1 2025 372% -165% -31% 31 Mar 2025
Q4 2024 393% -113% -22% 31 Dec 2024
Q3 2024 418% -66% -14% 30 Sep 2024
Q2 2024 448% -8% -1.8% 30 Jun 2024
Q1 2024 537% +69% +15% 31 Mar 2024
Q4 2023 506% +5% +0.91% 31 Dec 2023
Q3 2023 484% -80% -14% 30 Sep 2023
Q2 2023 456% -228% -33% 30 Jun 2023
Q1 2023 468% -365% -44% 31 Mar 2023
Q4 2022 501% -536% -52% 31 Dec 2022
Q3 2022 564% -482% -46% 30 Sep 2022
Q2 2022 684% -311% -31% 30 Jun 2022
Q1 2022 833% -115% -12% 31 Mar 2022
Q4 2021 1037% +166% +19% 31 Dec 2021
Q3 2021 1045% -47% -4.3% 30 Sep 2021
Q2 2021 995% -149% -13% 30 Jun 2021
Q1 2021 948% -166% -15% 31 Mar 2021
Q4 2020 871% -239% -22% 31 Dec 2020
Q3 2020 1093% +6% +0.52% 30 Sep 2020
Q2 2020 1144% -220% -16% 30 Jun 2020
Q1 2020 1114% 31 Mar 2020
Q4 2019 1110% 31 Dec 2019
Q3 2019 1087% 30 Sep 2019
Q2 2019 1364% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.